Why do fewer people with cystic fibrosis get COVID-19? new study investigates
NCT ID NCT05745948
First seen Feb 28, 2026 · Last updated Apr 28, 2026 · Updated 8 times
Summary
This study looked at whether people with cystic fibrosis (CF) have natural protection against COVID-19. Researchers tested blood samples from 75 children and adults with CF in Europe for SARS-CoV-2 antibodies over two years. They compared antibody levels after natural infection versus vaccination, and tracked how COVID-19 affected lung function and CF symptoms. The goal was to understand why fewer CF patients report COVID-19 cases and whether their immune response differs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitari Vall d'Hebron. Cystic Fibrosis Unit
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.